|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effectiveness of an intervention for reducing social stigma towards mental illness in adolescents显示文摘AIM: To evaluate the effectiveness of an intervention for reducing social stigma towards mental illness in adolescents. The effect of gender and knowledge of someone with mental illness was measured. METHODS: Two hundred and eighty secondary school students were evaluated using the Community Attitudes towards Mental Illness(CAMI) questionnaire. The schools were randomized and some received the intervention and others acted as the control group. The programme consisted of providing information via a documentary film and of contact with healthcare staff in order to reduce the social stigma within the school environment. RESULTS: The intervention was effective in reducing the CAMI authoritarianism and social restrictiveness subscales. The intervention showed significant changes in girls in terms of authoritarianism and social restrictiveness, while boys only showed significant changes in authoritarianism. Following the intervention, a significant reduction was found in authoritarianism and social restrictiveness in those who knew someone with mental illness, and only in authoritarianism in those who did not know anyone with mental illness. CONCLUSION: The intervention was effective to reduce social stigma towards people with mental illness, especially in the area of authoritarianism. Some differences were found depending on gender and whether or not the subjects knew someone with mental illness. | Regina Vila-Badia Francisco Martínez-Zambrano Otilia Arenas Emma Casas-Anguera Esther García-Morales Raúl Villellas José Ramón Martín María Belén Pérez-Franco Tamara Valduciel Diana Casellas Mar García-Franco Jose Miguel Joaquim Balsera Gemma Pascual Eugènia Julia Susana Ochoa | 2016 | World Journal of Psychiatry2016，6，2： | 4 |
| 2 | 在经历 transcatheter 的病人的 atrial 纤维性颤动的临床、预示的含意大动脉的阀门培植显示文摘 AIM: To study a cohort of consecutive patients under-going transcatheter aortic valve implantation (TAVI) and compare the outcomes of atrial fibrillation (AF) patients vs patients in sinus rhythm (SR). METHODS: All consecutive patients undergoing TAVI in our hospital were included. The AF group comprised patients in AF at the time of TAVI or with history of AF, and were compared with the SR group. Procedural, echocardiographic and follow-up variables were compared. Likewise, the CHA 2 DS 2-VASC stroke risk score and HAS-BLED bleeding risk score and antithrombotic treatment at discharge in AF patients were compared with that in SR patients. RESULTS: From a total of 34 patients undergoing TAVI, 17 (50%) were allocated to the AF group, of whom 15 (88%) were under chronic oral anticoagulation. Patients in the AF group were similar to those in the SR group except for a trend (P = 0.07) for a higher logistic EuroSCORE (28% vs 19%), and a higher prevalence of hypertension (82% vs 53%) and chronic renal failure (17% vs 0%). Risk of both stroke and bleeding was high in the AF group (mean CHA 2 DS 2-VASC 4.3, mean HAS-BLED 2.9). In the AF group, treatment at discharge included chronic oral anticoagulation in all except one case, and in association with an antiplatelet drug in 57% of patients. During a mean follow-up of 11 mo (maximum 32), there were only two strokes, none of them during the peri-procedural period: one in the AF group at 30 mo and one in the SR group at 3 mo. There were no statistical differences in procedural success, and clinical outcome (survival at 1 year 81% vs 74% in AF and SR groups, respectively, P = NS). CONCLUSION: Patients in AF undergoing TAVI show a trend to a higher surgical risk. However, in our cohort, patients in AF did not have a higher stroke rate compared to the SR group, and the prognosis was similar in both groups. | Pablo Salinas Raúl Moreno Luis Calvo Santiago Jiménez-Valero Guillermo Galeote Angel Sánchez-Recalde Teresa López-Fernández Sergio Garcia-Blas Diego Iglesias Luis Riera Isidro Moreno-Gómez Jose María Mesa Ignacio Plaza Rocio Ayala Rosa Gonzalez José-Luis López-Sendón | 2012 | World Journal of Cardiology2012，4，1： | 2 |
| 3 | A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis显示文摘 | Nadia Ashour Javier C. Angulo Guillermo Andrés Raúl Alelú Ana González‐Corpas María V. Toledo José M. Rodríguez‐Barbero Jose I. López Manuel Sánchez‐Chapado Santiago Ropero | 2014 | Prostate2014，，： | 1 |
| 4 | Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction显示文摘 | Broos K Trekels M Jose RA | | 0，，12： | 1 |
| 5 | Racial differences in primary central nervous system lymphoma incidence and survival rates显示文摘 | Jose S Pulido RA Vierkant JE | 2009 | Neuro Oncol2009，11，3： | 1 |
| 6 | Glucocorticoid inhibition of RANTES expression in human lung epithelial cells显示文摘 | Kwon OJ Jose PJ Robbins RA | 1995 | Am J Respir Cell Mol Biol1995，12，5： | 1 |
| 7 | Dopamine receptor coupling defect in hypertension显示文摘 | Eisner GM Felder RA | 2002 | Curr Hypertension Rep2002，4，： | 1 |
| 8 | Evaluating the tools used to assess the medical home 显示文摘 | Malouin RA Starfield B Martin Jose S | 2009 | Managed Care2009，18，6： | 1 |
| 9 | Pharmacokinetics of tramadol enantiomers and their respective phase Ⅰ metabolites in relation to CYP2D6 phenotype显示文摘 | Emilio GQ Jose RA Belen S | 2007 | Pharmacol Res2007，55，： | 1 |
| 10 | Role of dopamine receptors in the kidney in the regulation of blood pressure显示文摘 | Jose PA Eisner GM Felder RA | 2002 | Curr Opin Nephrol Hypertens2002，11，： | 1 |
| 11 | Regulation of blood pressure by dopamine receptors显示文摘 | Jose PA Eisner GM Felder RA | 2003 | Nephron Physiol2003，95，： | 1 |
| 12 | Role of dopamine receptors in the kidney in the regulation of blood pressure 显示文摘 | Jose PA Eisner GM Felder RA | 2002 | Curr Opin Nephrol Hyertens2002，11，： | 1 |
| 13 | Renal dopamine receptors in health and hypertension显示文摘 | Eisner GM Felder RA | 1998 | Pharmacol Ther1998，80，： | 1 |
| 14 | Role of dopamine receptors in the kidney in the reguLation of blood pressure 显示文摘 | Jose PA Eisner GM Felder RA | 2002 | Curt Opin Nephrol Hypertens2002，11，： | 1 |
| 15 | D1 dopamine receptor signaling defect in spontaneous hypertension显示文摘 | Eisner GM Jose PA | 2000 | Acta Physiol Scand2000，168，： | 1 |
| 16 | Renal dopamine receptors in health and hypertension显示文摘 | Jose PA Eisner GM Felder RA | 1998 | Pharmacol Ther1998，80，： | 1 |
| 17 | Coor i nat ion a nd continuity ofintenaive care unit patient care显示文摘 | M il le rA Schei n keglelC Jose ph M | 2009 | Hum Factors2009，51，3： | 1 |
| 18 | A new approach for treatment of hypertension: modifying DI dopamine receptor function 显示文摘 | Zeng C Felder RA Jose PA | 2006 | Cardiovasc Hematol Agents Med Chem2006，4，4： | 1 |
| 19 | Regulation of blood pressure by dopamine receptor显示文摘 | Eisner GM Felder RA | 2003 | Nephron Physiol2003，95，2： | 1 |
| 20 | Regulation of blood pressure by dopamine receptors显示文摘 | Jose PA Eisner GM Felder RA | 2003 | Nephron Physiol2003，95，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员